Lundgaard Maja Hjelm, Bruun Niels Henrik, Andersen Stig, Andersen Stine Linding
Eur Thyroid J. 2025 Jul 9;14(4). doi: 10.1530/ETJ-25-0111. Print 2025 Aug 1.
Hypothyroidism in pregnant women has been linked to deviations in birth weight, but associations are not consistent and the role of confounding factors, including maternal body mass index (BMI), is not clear. This study aimed to evaluate the association between maternal hypothyroidism, birth weight of the child, and placental weight.
This was a retrospective register-based study of singleton live births in Denmark from 2004 to 2015 (n = 694,734). Small for gestational age (SGA) (<10th percentile), large for gestational age (LGA) (>90th percentile), and placental weight Z-scores were defined according to gestational week at birth and sex of the child. Associations were evaluated using logistic and linear regression, adjusting for potential confounders, which included maternal BMI.
Altogether, 9.8 and 9.9% of pregnant women with no diagnosis of hypothyroidism gave birth to SGA and LGA children. The frequency of SGA was higher among children whose mothers were newly diagnosed with hypothyroidism in pregnancy (12.4%; adjusted odds ratio (aOR) = 1.16 (95% confidence interval (CI): 1.00-1.34)), but not LGA (9.3%; aOR = 1.03 (95% CI: 0.87-1.21)). Children born to mothers with treated hypothyroidism in pregnancy did not have higher frequencies of SGA (aOR = 0.94 (95% CI: 0.86-1.03)) or LGA (aOR = 1.06 (95% CI: 0.98-1.14)). No association between maternal hypothyroidism and placental weight Z-score was found (adjusted beta coefficient: 0.004 (95% CI: -0.016; 0.024)).
The findings from a large Danish cohort point toward an association between hypothyroidism in pregnancy and lower birth weight of the child, whereas no association with placental weight was found.
孕妇甲状腺功能减退与出生体重偏差有关,但这种关联并不一致,包括孕妇体重指数(BMI)在内的混杂因素的作用尚不清楚。本研究旨在评估孕妇甲状腺功能减退、孩子出生体重和胎盘重量之间的关联。
这是一项基于丹麦2004年至2015年单胎活产登记的回顾性研究(n = 694,734)。根据出生孕周和孩子性别定义小于胎龄儿(SGA)(<第10百分位数)、大于胎龄儿(LGA)(>第90百分位数)和胎盘重量Z评分。使用逻辑回归和线性回归评估关联,并对包括孕妇BMI在内的潜在混杂因素进行调整。
在未诊断为甲状腺功能减退的孕妇中,分别有9.8%和9.9%的孕妇生下了小于胎龄儿和大于胎龄儿。母亲在孕期新诊断为甲状腺功能减退的孩子中,小于胎龄儿的发生率更高(12.4%;调整后的优势比(aOR)= 1.16(95%置信区间(CI):1.00 - 1.34)),但大于胎龄儿的发生率并非如此(9.3%;aOR = 1.03(95% CI:0.87 - 1.21))。孕期接受甲状腺功能减退治疗的母亲所生的孩子,小于胎龄儿(aOR = 0.94(95% CI:0.86 - 1.03))或大于胎龄儿(aOR = 1.06(95% CI:0.98 - 1.14))的发生率均未升高。未发现孕妇甲状腺功能减退与胎盘重量Z评分之间存在关联(调整后的β系数:0.004(95% CI: - 0.016;0.024))。
丹麦一个大型队列的研究结果表明,孕期甲状腺功能减退与孩子出生体重较低之间存在关联,而与胎盘重量无关。